Quantum BioPharma Ltd.

DB:0K91 Stock Report

Market Cap: €8.0m

Quantum BioPharma Management

Management criteria checks 4/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Key information

Zeeshan Saeed

Chief executive officer

US$599.9k

Total compensation

CEO salary percentage37.1%
CEO tenure3.3yrs
CEO ownership6.3%
Management average tenure3.2yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Zeeshan Saeed's remuneration changed compared to Quantum BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Compensation vs Market: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).

Compensation vs Earnings: Zeeshan's compensation has been consistent with company performance over the past year.

CEO

Zeeshan Saeed (54 yo)

3.3yrs

Tenure

US$599,873

Compensation

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...

Leadership Team

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Founder3.3yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Donal Carroll
CFO & COO3.3yrsUS$602.87k4.44%
€ 356.6k
Nathan Coyle
Controllerless than a yearUS$178.21k0.13%
€ 10.8k
Lakshmi Kotra
CEO of Lucid & Director3.2yrsUS$521.97k1.17%
€ 94.3k
Jason Sawyer
Head of Finance & Mergers and Acquisitionsless than a yearno datano data
Maryann Adesso
Corporate Secretaryno datano datano data
Randell Mack
President of FSD BioSciences3.7yrsno datano data
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
€ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kno data

3.2yrs

Average Tenure

48yo

Average Age

Experienced Management: 0K91's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Founder3.5yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Lakshmi Kotra
CEO of Lucid & Director2yrsUS$521.97k1.17%
€ 94.3k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.8yrsno datano data
Eleanor Fish
Member of Research & Clinical Advisory Board3yrsno datano data
Hance Clarke
Member of Research & Clinical Advisory Board3.2yrsno datano data
Eric Hoskins
Independent Director1.5yrsno datano data
Adnan Bashir
Independent Director3.4yrsUS$139.37k0.0077%
€ 620.5
Peter Stys
Member of Research & Clinical Advisory Board3.2yrsno datano data
Shannon Dunn
Member of Research & Clinical Advisory Board3.2yrsno datano data
Albert Wong
Member of Research & Clinical Advisory Board3.2yrsno datano data
Joga Gobburu
Member of Regulatory Advisory Board3yrsno datano data

3.2yrs

Average Tenure

54yo

Average Age

Experienced Board: 0K91's board of directors are considered experienced (3.2 years average tenure).